A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis

NCT06559150 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
284
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA